Rich S. Nelson - 03 Mar 2022 Form 4 Insider Report for vTv Therapeutics Inc. (VTVT)

Reporting relationship: Acting Chief Executive Officer, Director
Issuer ticker: VTVT
Reported as of: 03 Mar 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 04 Mar 2022, 19:51:39 UTC
Source filing: View source filing
Reporting owner signature: /s/ Rich S. Nelson

Key filing fact

Rich S. Nelson filed Form 4 for vTv Therapeutics Inc. (VTVT) on 04 Mar 2022.

Key facts

This page summarizes Rich S. Nelson's Form 4 filing for vTv Therapeutics Inc. (VTVT).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 04 Mar 2022, 19:51.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VTVT transaction Derivative

Employee stock option (right to buy)

Award

Transaction value: $0
Shares: +500,000
Change %
Price: $0.000000
Shares after: 500,000
Date: 03 Mar 2022
Ownership: Direct
Underlying class: Class A common stock
Underlying amount: 500,000
Exercise price: $0.8060
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

125,000 of the options vested on the date of grant and the remaining 375,000 options vest quarterly at rate of 31,250 every three months over three years beginning from March 1, 2022 subject to continued services as an employee or director.